Zobrazeno 1 - 10
of 43
pro vyhledávání: '"EBRU TAŞTEKİN"'
Autor:
İvo Gökmen, Ebru Taştekin, Nazan Demir, Erkan Özcan, Fahri Akgül, Muhammed Bekir Hacıoğlu, Bülent Erdoğan, Sernaz Topaloğlu, İrfan Çiçin
Publikováno v:
Current Issues in Molecular Biology, Vol 45, Iss 10, Pp 7803-7812 (2023)
The aim of our study was to evaluate the incidence of KRAS/NRAS and BRAF mutations, analyze molecular patterns, and investigate associations with clinical parameters of these mutations in CRC KRAS/NRAS and BRAF mutations analyzed by next-generation s
Externí odkaz:
https://doaj.org/article/136914033b38496a91f9524dc2a50894
Autor:
Ufuk Usta, Ebru Taştekin
Publikováno v:
Balkan Medical Journal, Vol 41, Iss 3, Pp 157-158 (2024)
Externí odkaz:
https://doaj.org/article/e28cdb16b41e4b00916132c8808ffc5a
Autor:
İrfan Yıldırım Şentürk, Müslim Doğan Değer, Muhammed Ali Aydın, Serdar Madendere, Oktay Kaya, Ebru Taştekin, Tevfik Aktoz
Publikováno v:
Journal of Urological Surgery, Vol 10, Iss 2, Pp 167-172 (2023)
Objective:This study demonstrated the protective effects of pioglitazone (Pio) on testicular torsion/detorsion-induced ischemia-reperfusion (I/R) injury.Materials and Methods:A total of 48 male rats were randomly divided into six experimental groups
Externí odkaz:
https://doaj.org/article/cc33287054a34563b4c52190de8c04c6
The Effects of Irisin on Nω-Nitro-L-arginine Methyl Ester Hydrochloride-Induced Hypertension in Rats
Autor:
Nurettin Aydoğdu, Özlem Yalçınkaya Yavuz, Ebru Taştekin, Pınar Tayfur, Oktay Kaya, Nihayet Kandemir
Publikováno v:
Balkan Medical Journal, Vol 36, Iss 6, Pp 337-346 (2019)
Background: The cause of about 95% of hypertension, an important public health problem, is unknown. Intensive studies are underway to understand the physiopathology of hypertension. Irisin, a newly discovered hormone, has been reported to dilate vasc
Externí odkaz:
https://doaj.org/article/cffb740dff844791b07a10dda64e5300
Autor:
İBRAHİM ETHEM CAKCAK, YUSUF EMRE AYTİN, SEZİN SAYIN, AHMET KÜÇÜKARDA, ALİ GÖKYER, İVO GÖKMEN, ERKAN ÖZCAN, SELÇUK KORKMAZ, EBRU TAŞTEKİN, İRFAN ÇİÇİN
Publikováno v:
Turkish Journal of Medical Sciences. 53:51-57
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff1d1e0d88dbb6602acdfecc329495b6
https://doi.org/10.55730/1300-0144.5557
https://doi.org/10.55730/1300-0144.5557
Autor:
Nuray CAN, Ebru TAŞTEKIN, Tülin DENIZ YALTA, Necdet SÜT, Selma KORKMAZ, Ufuk USTA, Fulya ÖZ PUYAN, Ezgi GENÇ, Mert CEZIK, Busem BINBOĞA TUTUĞ, Osman KÖSTEK, Hilmi TOZKIR
Publikováno v:
Türk Patoloji Dergisi, Vol 34, Iss 2, Pp 134-142 (2018)
Objective: BRAF is the most common mutation in melanoma. The most common subtype is BRAF V600E, followed by V600K. Initially, the authors aimed to investigate whether clinicopathological features of melanoma are associated with BRAF mutations. We the
Externí odkaz:
https://doaj.org/article/c7410c8419314fd996c3fa6d2a221ba6
Publikováno v:
Balkan Medical Journal, Vol 35, Iss 1, Pp 68-76 (2018)
Background: Myoglobinuric acute kidney injury is a uremic syndrome that develops due to damage of skeletal muscle. Free radicals and nitric oxide play an important role in the pathogenesis of myoglobinuric acute kidney injury. Baicalin has multiple b
Externí odkaz:
https://doaj.org/article/f9320e8a57434552be8c52b23774c8da
Publikováno v:
Balkan Medical Journal, Vol 38, Iss 2, Pp 135-136 (2021)
Externí odkaz:
https://doaj.org/article/91f8cd5b7d2d4009980f51dcafd75e95
Autor:
Hilmi Kodaz, Ebru Taştekin, Bülent Erdoğan, İlhan Hacıbekiroğlu, Hilmi Tozkır, Hakan Gürkan, Esma Türkmen, Bora Demirkan, Sernaz Uzunoğlu, İrfan Çiçin
Publikováno v:
Balkan Medical Journal, Vol 33, Iss 4, Pp 407-410 (2016)
Background: Lung cancer is one of the most lethal cancers. It is mainly classified into 2 groups: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Extrapulmonary small cell carcinomas (EPSCC) are very rare. The Ras oncogene c
Externí odkaz:
https://doaj.org/article/fab15479e62246af84c115c23d1c58b6
Publikováno v:
Balkan Medical Journal, Vol 32, Iss 4, Pp 388-396 (2015)
Background: Gastrointestinal stromal tumors (GIST) have KIT or platelet-derived growth factor receptor α (PDGFRα) mutations affecting receptor tyrosine kinase activity and do not benefit from classic treatment regimens. Aims: The aim of this stu
Externí odkaz:
https://doaj.org/article/0edbe9c4a8f041c98b6d95180b88cda8